Updated:
De Novo Ventures
De Novo Ventures is a venture capital firm investing in seed, startup, and emerging growth companies in medical device and biotechnology sectors.
De Novo Ventures
De Novo Ventures is a venture capital firm investing in seed, startup, and emerging growth companies in medical device and biotechnology sectors. The firm has made 158 investments, including a Series A investment in Milo on January 11, 2023. De Novo Ventures has facilitated 30 portfolio exits, with EndoGastric Solutions exiting on July 01, 2024.
General information
Firm type
Venture Capital
Year founded
2000
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Burlingame
Corporate office
Burlingame, United States
Frequently asked questions
What stages does De Novo Ventures target?
Records list coverage across early-stage seed, start-up, expansion, late-stage, growth, and general venture.
Where is De Novo Ventures headquartered?
The firm is based in Burlingame, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: